Suppr超能文献

仿生载金纳米壳巨噬细胞用于光热生物医学

Biomimetic Gold Nanoshell-Loaded Macrophage for Photothermal Biomedicine.

机构信息

Department of Biomedical Sciences, College of Medicine, Hallym University, Chuncheon 24252, Republic of Korea.

Department of Chemical and Biological Engineering, Korea National University of Transportation, Chungju 27469, Republic of Korea.

出版信息

Biomed Res Int. 2020 Apr 14;2020:5869235. doi: 10.1155/2020/5869235. eCollection 2020.

Abstract

The purpose of this study was to investigate the effect of photothermal treatment (PTT) with gold nanoshell (ANS) using a macrophage-mediated delivery system in a head and neck squamous cell carcinoma (HNSCC) cell line. To achieve this, ANS-loaded rat macrophages (ANS-MAs) were prepared via the coculture method with ANS. The human HNSCC (FaDu cell) and macrophage (rat macrophage; NR8383 cell) hybrid spheroid models were generated by the centrifugation method to determine the possibility of using ANS-MAs as a cancer therapy. These ANS-MAs were set into the tumor and macrophage hybrid spheroid model to measure PTT efficacy. Kinetic analysis of the spheroid growth pattern revealed that this PTT process caused a decreasing pattern in the volume of the hybrid model containing ANS-MAs ( < 0.001). Comparison with empty macrophages showed harmony between ANS and laser irradiation for the generation of PTT. An annexin V/dead cell marker assay indicated that the PTT-treated hybrid model induced increasing apoptosis and dead cells. Further studies on the toxicity of ANS-MAs are needed to reveal whether it can be considered biocompatible. In summary, the ANS was prepared with a macrophage as the delivery method and protective carrier. The ANS was successfully localized to the macrophages, and their photoabsorption property was stationary. This strategy showed significant growth inhibition of the tumor and macrophage spheroid model under NIR laser irradiation. In vivo toxicology results suggest that ANS-MA is a promising candidate for a biocompatible strategy to overcome the limitations of fabricated nanomaterials. This ANS-MA delivery and PTT strategy may potentially lead to improvements in the quality of life of patients with HNSCC by providing a biocompatible, minimally invasive modality for cancer treatment.

摘要

本研究旨在探讨利用金纳米壳(ANS)介导的巨噬细胞递药系统进行光热治疗(PTT)对头颈部鳞状细胞癌(HNSCC)细胞系的影响。为此,通过共培养方法用 ANS 制备负载 ANS 的大鼠巨噬细胞(ANS-MA)。通过离心法生成人 HNSCC(FaDu 细胞)和巨噬细胞(大鼠巨噬细胞;NR8383 细胞)混合球体模型,以确定将 ANS-MA 用作癌症治疗的可能性。将这些 ANS-MA 置于肿瘤和巨噬细胞混合球体模型中以测量 PTT 疗效。球体生长模式的动力学分析表明,该 PTT 过程导致含有 ANS-MA 的混合模型的体积呈下降趋势(<0.001)。与空巨噬细胞的比较表明,ANS 和激光照射之间的和谐关系可用于产生 PTT。Annexin V/死亡细胞标记测定表明,PTT 处理的混合模型诱导凋亡和死亡细胞增加。需要进一步研究 ANS-MA 的毒性,以揭示其是否可被认为是生物相容的。总之,用巨噬细胞作为递送方法和保护载体制备了 ANS。成功地将 ANS 定位到巨噬细胞中,并且其光吸收特性是稳定的。该策略在 NIR 激光照射下显示出对肿瘤和巨噬细胞球体模型的显著生长抑制作用。体内毒理学结果表明,ANS-MA 是克服纳米材料制造局限性的有前途的生物相容策略的候选者。这种 ANS-MA 递药和 PTT 策略可能通过为癌症治疗提供生物相容的微创方式来提高 HNSCC 患者的生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f6d/7178525/3b929087b390/BMRI2020-5869235.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验